Jiangsu Alphamab Biopharmaceuticals Co., Ltd

This study tests a new drug called JSKN033 in 160 people with advanced non-small cell lung cancer that cannot be cured. The goal is to see if the drug is safe and shrinks tumors. The trial has two parts: first finding the best dose, then testing it in more patients.

This study tests a new drug called JSKN033 combined with standard chemotherapy, with or without another drug (bevacizumab), in people with advanced cervical cancer that has come back or spread. The goal is to see if the combination is safe and helps shrink or control tumors. Abou…

This early-stage study tests a new drug, JSKN027, in 250 people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. The study is done in two parts: firs…